Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517640
What this trial is testing
Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
Who this might be right for
Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 45